Painkillers May Raise Heart Attack Risk Slightly
Posted on: Tuesday, 1 August 2006, 20:55 CDT
NEW YORK -- All painkillers of the type known as nonsteroidal anti-inflammatory drugs (NSAIDs) seem to increase the risk of having a heart attack, according to a population-based study conducted in Finland.
The finding applies not only to selective COX-2 inhibitors such as celecoxib but also to non-selective drugs like ibuprofen or naproxen.
"Our results do not support the view that COX-selectivity alone determines the cardiovascular adverse effects of NSAIDs," lead investigator Dr. Arja Helin-Salmivaara and colleagues note in the European Heart Journal.
Accumulating data on the cardiovascular risks associated with COX-2 inhibitors have called into question the safety of nonselective NSAIDs, they note.
The investigators evaluated data for 33,309 heart attack patients entered into the Finnish Hospital Discharge Register between 2000 and 2003. These subjects were compared with 138,949 matched "control" subjects.
Helin-Salmivaara from the University of Turku, in Helsinki, and colleagues found that current use of any type of NSAID was associated with 40 percent increased risk of having a heart attack.
The risk of having a heart attack tended to decline over time after discontinuation of NSAID use, but this trend reached statistical significance only for nonselective NSAIDs.
Still, "even if the risk increase was modest, any risk of serious adverse events is important at the population level if a drug is not life-saving and is widely used, as is the case with NSAIDs," the researchers conclude.
In a related editorial, Dr. Deepak L. Bhatt, from Cleveland Clinic Foundation in Ohio, points out that the report by the Finnish team is the largest population-based study of NSAIDs performed to date.
Because other studies have yielded different results, and some researchers have suggested that NSAIDs may actually protect the heart, a large clinical trial is needed. To that end, Bhatt and his associates have launched a forward-looking trial to evaluate the safety of celecoxib, ibuprofen and naproxen among 20,000 patients with arthritis, either with cardiovascular disease or at high risk.
SOURCE: European Heart Journal, July 2006.
Source: REUTERS
Related Articles
- New Analysis Suggests That Improvements in Kidney Function in Patients Treated With Lipitor Strongly Correlate With a Reduced Risk of Major Cardiovascular Events
- Brigham and Women's Hospital and Celera Publish Results Demonstrating That Carriers of a Variant of the LPA Gene Have More Than Two-Fold Higher Risk of Major Cardiovascular Events and That This Risk is Eliminated By Aspirin Therapy
- Study: Hispanic Women's Hearts at Risk
- Diabetic Kids often Have Heart-disease Risk Factors
- Air Pollution Shown to Increase Heart Disease Risk
- Heart disease risk tool fails in women: study
- Weight-loss Surgery Produces Unexpected Drop in Heart Disease Risk
- Weight-Loss Surgery Produces Unexpected Drop in Heart Disease Risk, Stanford Researchers Find
- Vitamin E Supplements Might Increase Heart Failure Risks Forcertain Patients
- Women Should Cut Heart Disease Risks Before Menopause
 |
 |
User Comments (0)
RSS Feeds